Literature for peptidase M23.004: lysostaphin

(Topics flags: A Assay, S Structure, P Specificity, E Expression, U Therapeutic, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

2024
1. Antenucci,L., Virtanen,S., Thapa,C., Jartti,M., Pitkanen,I., Tossavainen,H. and Permi,P.
   Reassessing the substrate specificities of the major Staphylococcus aureus peptidoglycan hydrolases lysostaphin and LytM
   elife13, PubMed  Europe PubMed DOI
2023
2. Charoenjotivadhanakul,S., Sakdee,S., Imtong,C., Li,H.C. and Angsuthanasombat,C.
   Conserved loop residues-Tyr(270) and Asn(372) near the catalytic site of the lysostaphin endopeptidase are essential for staphylolytic activity toward pentaglycine binding and catalysis
   Biochem Biophys Res Commun668, 111-117. PubMed  Europe PubMed DOI
3. Shestak,N.V., Grishin,A.V., Lyashchuk,A.M., Lunin,V.G. and Karyagina,A.S.
   The choice of chromatographic resin for the purification of recombinant lysostaphin affects its activity
   Protein Expr Purif207, 106274-106274. PubMed  Europe PubMed DOI
2022
4. Konstantinova,S., Grishin,A., Lyashchuk,A., Vasina,I., Karyagina,A. and Lunin,V.
   Influence of NaCl and pH on lysostaphin catalytic activity, cell binding, and bacteriolytic activity
   Appl Microbiol Biotechnol106, 6519-6534. PubMed  Europe PubMed DOI
5. Siddiqui,F., Ulker,M., Laizure,I.E. and Johnson,K.C.
   Engineered device in E. coli lyses S. aureus at physiological fever temperatures
   MicroPubl Biol2022, PubMed  Europe PubMed DOI
6. Zha,J., Li,J., Su,Z., Akimbekov,N. and Wu,X.
   Lysostaphin: Engineering and Potentiation toward Better Applications
   J Agric Food Chem70, 11441-11457. PubMed  Europe PubMed DOI
2021
7. Bonar,E., Bukowski,M., Chlebicka,K., Madry,A., Bereznicka,A., Kosecka-Strojek,M., Dubin,G., Miedzobrodzki,J., Mak,P. and Wladyka,B.
   Human skin microbiota-friendly lysostaphin
   Int J Biol Macromol183, 852-860. PubMed  Europe PubMed DOI
8. Duman-Ozdamar,Z.E., Unlu,A., Unal,H., Woodley,J.M. and Bi Nay,B.
   High-yield production of active recombinant S. simulans lysostaphin expressed in E. coli in a laboratory bioreactor
   Protein Expr Purif177, 105753-105753. PubMed  Europe PubMed DOI
9. Ye,G., Huang,J., Li,G., Zhang,J., Sun,Y., Zeng,D., Bao,W., Zhong,J. and Huang,Q.
   Clinical efficacy of intravaginal recombinant lysostaphin administration on endometritis in sows
   Vet Med Sci7, 746-754. PubMed  Europe PubMed DOI
2020
10. Batool,N., Ko,K.S., Chaurasia,A.K. and Kim,K.K.
    Functional Identification of Serine Hydroxymethyltransferase as a Key Gene Involved in Lysostaphin Resistance and Virulence Potential of Staphylococcus aureus Strains
    Int J Mol Sci21, PubMed  Europe PubMed DOI
11. Cheleuitte-Nieves,C.E., Diaz,L.L., de la Gandara,M.P., Gonzalez,A., Freiwald,W.A., de Lencastre,H.M., Tomasz,A. and Euler,C.W.
    Evaluation of Topical Lysostaphin as a Novel Treatment for Instrumented Rhesus Macaques (Macaca mulatta) Infected with Methicillin- Resistant Staphylococcus aureus
    Comp Med PubMed  Europe PubMed DOI
12. Fang,Y., Kirsch,J.R., Li,L., Brooks,S.A., Heim,S., Tan,C., Eszterhas,S., Cheng,H.D., Zhao,H., Xiong,Y.Q. and Griswold,K.E.
    Deimmunized Lysostaphin Synergizes with Small-molecule Chemotherapies and Re-sensitizes MRSA to beta-Lactam Antibiotics
    Antimicrob Agents Chemother PubMed  Europe PubMed DOI
13. Gonzalez-Delgado,L.S., Walters-Morgan,H., Salamaga,B., Robertson,A.J., Hounslow,A.M., Jagielska,E., Sabala,I., Williamson,M.P., Lovering,A.L. and Mesnage,S.
    Two-site recognition of Staphylococcus aureus peptidoglycan by lysostaphin SH3b
    Nat Chem Biol16, 24-30. PubMed  Europe PubMed DOI
14. Grishin,A.V., Konstantinova,S.V., Vasina,I.V., Shestak,N.V., Karyagina,A.S. and Lunin,V.G.
    A Simple Protocol for the Determination of Lysostaphin Enzymatic Activity
    Antibiotics (Basel)9, PubMed  Europe PubMed DOI
15. Jayakumar,J., Kumar,V.A., Biswas,L. and Biswas,R.
    Therapeutic applications of lysostaphin against Staphylococcus aureus
    J Appl Microbiol PubMed  Europe PubMed DOI  V
16. Vacek,L., Kobzova,S., Cmelik,R., Pantucek,R. and Janda,L.
    Enzybiotics LYSSTAPH-S and LYSDERM-S as Potential Therapeutic Agents for Chronic MRSA Wound Infections
    Antibiotics (Basel)9, PubMed  Europe PubMed DOI
17. Willing,S., Dyer,E., Schneewind,O. and Missiakas,D.
    FmhA and FmhC of Staphylococcus aureus incorporate serine residues into peptidoglycan crossbridges
    J Biol Chem295, 13664-13676. PubMed  Europe PubMed DOI
2019
18. Duman,Z.E., Unlu,A., Cakar,M.M., Unal,H. and Binay,B.
    Enhanced production of recombinant Staphylococcus simulans lysostaphin using medium engineering
    Prep Biochem Biotechnol49, 521-528. PubMed  Europe PubMed DOI  E
19. Grishin,A.V., Lavrova,N.V., Lyashchuk,A.M., Strukova,N.V., Generalova,M.S., Ryazanova,A.V., Shestak,N.V., Boksha,I.S., Polyakov,N.B., Galushkina,Z.M., Soboleva,L.A., Vetchinin,S.S., Pavlov,V.M., Karyagina,A.S. and Lunin,V.G.
    The influence of dimerization on the pharmacokinetics and activity of an antibacterial enzyme lysostaphin
    Molecules24, PubMed  Europe PubMed DOI
20. Madry,A., Jendroszek,A., Dubin,G. and Wladyka,B.
    Production of lysostaphin by nonproprietary method utilizing a promoter from toxin-antitoxin system
    Mol Biotechnol61, 774-782. PubMed  Europe PubMed DOI  E
21. Mitkowski,P., Jagielska,E., Nowak,E., Bujnicki,J.M., Stefaniak,F., Niedzialek,D., Bochtler,M. and Sabala,I.
    Structural bases of peptidoglycan recognition by lysostaphin SH3b domain
    Sci Rep9, 5965-5965. PubMed  Europe PubMed DOI  S
2018
22. Chandra Ojha,S., Imtong,C., Meetum,K., Sakdee,S., Katzenmeier,G. and Angsuthanasombat,C.
    Purification and characterization of the antibacterial peptidase lysostaphin from Staphylococcus simulans: adverse influence of Zn(2+) on bacteriolytic activity
    Protein Expr Purif151, 106-112. PubMed  Europe PubMed DOI
23. Jin,J., Zhou,H., Cui,Z.C., Wang,L., Luo,P.F., Ji,S.Z., Hu,X.Y., Ma,B., Wang,G.Y., Zhu,S.H. and Xia,Z.F.
    [Antiseptic effect of compound lysostaphin disinfectant and its preventive effect on infection of artificial dermis after graft on full-thickness skin defect wound in rats]
    Zhonghua Shao Shang Za Zhi34, 225-232. PubMed  Europe PubMed DOI  U
24. Johnson,C.T., Wroe,J.A., Agarwal,R., Martin,K.E., Guldberg,R.E., Donlan,R.M., Westblade,L.F. and Garcia,A.J.
    Hydrogel delivery of lysostaphin eliminates orthopedic implant infection by Staphylococcus aureus and supports fracture healing
    Proc Natl Acad Sci U S A115, E4960-E4960. PubMed  Europe PubMed DOI  U
25. Raz,A., Serrano,A., Thaker,M., Alston,T. and Fischetti,V.A.
    Lysostaphin lysibody leads to effective opsonization and killing of methicillin resistant Staphylococcus aureus in a murine model
    Antimicrob Agents Chemother62, e01056-18-e01056-18. PubMed  Europe PubMed DOI
26. Tossavainen,H., Raulinaitis,V., Kauppinen,L., Pentikainen,U., Maaheimo,H. and Permi,P.
    Structural and functional insights into lysostaphin-substrate interaction
    Front Mol Biosci5, 60-60. PubMed  Europe PubMed DOI  S
2017
27. Fernandez,L., Gonzalez,S., Campelo,A.B., Martinez,B., Rodriguez,A. and Garcia,P.
    Downregulation of autolysin-encoding genes by phage-derived lytic proteins inhibits biofilm formation in Staphylococcus aureus
    Antimicrob Agents Chemother61, e02724-16-e02724-16. PubMed  Europe PubMed DOI
28. Hathaway,H., Ajuebor,J., Stephens,L., Coffey,A., Potter,U., Sutton,J.M. and Jenkins,A.T.
    Thermally triggered release of the bacteriophage endolysin CHAPK and the bacteriocin lysostaphin for the control of methicillin resistant Staphylococcus aureus (MRSA)
    J Control Release245, 108-115. PubMed  Europe PubMed DOI  U
29. Lood,R., Molina,H. and Fischetti,V.A.
    Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Forster resonance energy transfer (FRET) assays
    PLoS ONE12, e0173919-e0173919. PubMed  Europe PubMed DOI  A
30. Raulinaitis,V., Tossavainen,H., Aitio,O., Seppala,R. and Permi,P.
    (1)H (13)C and (15)N resonance assignments of the new lysostaphin family endopeptidase catalytic domain from Staphylococcus aureus
    Biomol NMR Assign11, 69-73. PubMed  Europe PubMed DOI
31. Raulinaitis,V., Tossavainen,H., Aitio,O., Juuti,J.T., Hiramatsu,K., Kontinen,V. and Permi,P.
    Identification and structural characterization of LytU, a unique peptidoglycan endopeptidase from the lysostaphin family
    Sci Rep7, 6020-6020. PubMed  Europe PubMed DOI
2016
32. Abtahi,H., Farhangnia,L. and Ghaznavi-Rad,E.
    In vitro and in vivo antistaphylococcal activity determination of the new recombinant lysostaphin protein
    Jundishapur J Microbiol9, e28489-e28489. PubMed  Europe PubMed DOI  U
33. Filatova,L.Y., Donovan,D.M., Ishnazarova,N.T., Foster-Frey,J.A., Becker,S.C., Pugachev,V.G., Balabushevich,N.G., Dmitrieva,N.F. and Klyachko,N.L.
    A chimeric LysK-lysostaphin fusion enzyme lysing Staphylococcus aureus cells: a study of both kinetics of inactivation and specifics of interaction with anionic polymers
    Appl Biochem Biotechnol180, 544-557. PubMed  Europe PubMed DOI
2015
34. Blazanovic,K., Zhao,H., Choi,Y., Li,W., Salvat,R.S., Osipovitch,D.C., Fields,J., Moise,L., Berwin,B.L., Fiering,S.N., Bailey-Kellogg,C. and Griswold,K.E.
    Structure-based redesign of lysostaphin yields potent antistaphylococcal enzymes that evade immune cell surveillance
    Mol Ther Methods Clin Dev2, 15021-15021. PubMed  Europe PubMed DOI
2014
35. Chen,C., Fan,H., Huang,Y., Peng,F., Fan,H., Yuan,S. and Tong,Y.
    Recombinant lysostaphin protects mice from methicillin-resistant Staphylococcus aureus pneumonia
    Biomed Res Int2014, 602185-602185. PubMed  Europe PubMed DOI  U
36. Farhangnia,L., Ghaznavi-Rad,E., Mollaee,N. and Abtahi,H.
    Cloning, expression, and purification of recombinant lysostaphin from Staphylococcus simulans
    Jundishapur J Microbiol7, e10009-e10009. PubMed  Europe PubMed DOI  E
37. Sabala,I., Jagielska,E., Bardelang,P.T., Czapinska,H., Dahms,S.O., Sharpe,J.A., James,R., Than,M.E., Thomas,N.R. and Bochtler,M.
    Crystal structure of the antimicrobial peptidase lysostaphin from Staphylococcus simulans
    FEBS J281, 4112-4122. PubMed  Europe PubMed DOI  S
38. Sundarrajan,S., Raghupatil,J., Vipra,A., Narasimhaswamy,N., Saravanan,S., Appaiah,C., Poonacha,N., Desai,S., Nair,S., Bhatt,R.N., Roy,P., Chikkamadaiah,R., Durgaiah,M., Sriram,B., Padmanabhan,S. and Sharma,U.
    Bacteriophage-derived CHAP domain protein, P128, kills Staphylococcus cells by cleaving interpeptide cross-bridge of peptidoglycan
    Microbiology (Reading)160, 2157-2169. PubMed  Europe PubMed DOI
39. Zhao,H., Blazanovic,K., Choi,Y., Bailey-Kellogg,C. and Griswold,K.E.
    Gene and protein sequence optimization for high-level production of fully active and aglycosylated lysostaphin in Pichia pastoris
    Appl Environ Microbiol80, 2746-2753. PubMed  Europe PubMed DOI  E
2013
40. Huang,C.Y., Hsu,J.T., Chung,P.H., Cheng,W.T., Jiang,Y.N. and Ju,Y.T.
    Site-specific N-glycosylation of caprine lysostaphin restricts its bacteriolytic activity toward Staphylococcus aureus
    Anim Biotechnol24, 129-147. PubMed  Europe PubMed DOI  E
41. Lu,H.R., Gu,M.G., Huang,Q., Huang,J.J., Lu,W.Y., Lu,H. and Huang,Q.S.
    Hydrogen/deuterium exchange mass spectrometry and site-directed disulfide cross-linking suggest an important dynamic interface between the two lysostaphin domains
    Antimicrob Agents Chemother57, 1872-1881. PubMed  Europe PubMed DOI
2012
42. Kokai-Kun,J.F.
    Lysostaphin: a silver bullet for staph
    147-165.
43. Park,P.W. and Mecham,R.P.
    Lysostaphin
    [ISSN:978-0-12-407743-0]3, 1558-1560. DOI
44. Sabala,I., Jonsson,I.M., Tarkowski,A. and Bochtler,M.
    Anti-staphylococcal activities of lysostaphin and LytM catalytic domain
    BMC Microbiol12, 97-97. PubMed  Europe PubMed DOI
2011
45. Belyansky,I., Tsirline,V.B., Martin,T.R., Klima,D.A., Heath,J., Lincourt,A.E., Satishkumar,R., Vertegel,A. and Heniford,B.T.
    The addition of lysostaphin dramatically improves survival, protects porcine biomesh from infection, and improves graft tensile shear strength
    J Surg Res171, 409-415. PubMed  Europe PubMed DOI  U
46. Belyansky,I., Tsirline,V.B., Montero,P.N., Satishkumar,R., Martin,T.R., Lincourt,A.E., Shipp,J.I., Vertegel,A. and Heniford,B.T.
    Lysostaphin-coated mesh prevents staphylococcal infection and significantly improves survival in a contaminated surgical field
    Am Surg77, 1025-1031. PubMed  Europe PubMed  U
47. Cui,F., Li,G., Huang,J., Zhang,J., Lu,M., Lu,W., Huan,J. and Huang,Q.
    Development of chitosan-collagen hydrogel incorporated with lysostaphin (CCHL) burn dressing with anti-methicillin-resistant Staphylococcus aureus and promotion wound healing properties
    Drug Deliv18, 173-180. PubMed  Europe PubMed DOI  U
2010
48. Bastos,M.C.F., Coutinho,B.G. and Coelho,M.L.V.
    Lysostaphin: a staphylococcal bacteriolysin with potential clinical applications
    Pharmaceuticals3, 1139-1161. PubMed  Europe PubMed DOI  U
49. Cui,F., Li,G., Huang,J., Zhang,J., Lu,M., Lu,W. and Huang,Q.
    Extension of nasal anti-Staphylococcus aureus efficacy of lysostaphin by its incorporation into a chitosan-o/w cream
    Drug Deliv17, 617-623. PubMed  Europe PubMed DOI  U
50. Desbois,A.P., Lang,S., Gemmell,C.G. and Coote,P.J.
    Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA)
    J Appl Microbiol108, 723-730. PubMed  Europe PubMed DOI  U
51. Desbois,A.P., Gemmell,C.G. and Coote,P.J.
    In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections
    Int J Antimicrob Agents35, 559-565. PubMed  Europe PubMed DOI  U
52. Gargis,S.R., Heath,H.E., LeBlanc,P.A., Dekker,L., Simmonds,R.S. and Sloan,G.L.
    Inhibition of the activity of both domains of lysostaphin through peptidoglycan modification by the lysostaphin immunity protein
    Appl Environ Microbiol76, 6944-6946. PubMed  Europe PubMed DOI
2009
53. Bardelang,P., Vankemmelbeke,M., Zhang,Y., Jarvis,H., Antoniadou,E., Rochette,S., Thomas,N.R., Penfold,C.N. and James,R.
    Design of a polypeptide FRET substrate that facilitates study of the antimicrobial protease lysostaphin
    Biochem J418, 615-624. PubMed  Europe PubMed DOI  A
54. Huang,J., Wu,H., Zhang,J. and Huang,Q.
    [Purification of recombinant lysostaphin by monoclonal antibody affinity chromatography]
    Sheng Wu Gong Cheng Xue Bao25, 147-151. PubMed  Europe PubMed DOI
55. Kokai-Kun,J.F., Chanturiya,T. and Mond,J.J.
    Lysostaphin eradicates established Staphylococcus aureus biofilms in jugular vein catheterized mice
    J Antimicrob Chemother64, 94-100. PubMed  Europe PubMed DOI  U
56. Placencia,F.X., Kong,L. and Weisman,L.E.
    Treatment of methicillin-resistant Staphylococcus aureus in neonatal mice: lysostaphin versus vancomycin
    Pediatr Res65, 420-424. PubMed  Europe PubMed DOI  U
2008
57. Kumar,J.K.
    Lysostaphin: an antistaphylococcal agent
    Appl Microbiol Biotechnol80, 555-561. PubMed  Europe PubMed DOI  V  U
2007
58. Graham,S. and Coote,P.J.
    Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin
    J Antimicrob Chemother59, 759-762. PubMed  Europe PubMed DOI
59. Kokai-Kun,J.F., Chanturiya,T. and Mond,J.J.
    Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model
    J Antimicrob Chemother60, 1051-1059. PubMed  Europe PubMed DOI  U
60. Oluola,O., Kong,L., Fein,M. and Weisman,L.E.
    Lysostaphin in treatment of neonatal Staphylococcus aureus infection
    Antimicrob Agents Chemother51, 2198-2200. PubMed  Europe PubMed DOI  U
61. Surovtsev,V.I., Borzenkov,V.M., Fedorov,T.V. and Smotrov,O.I.
    Ionogenic groups in the active site of lysostaphin. Kinetic and thermodynamic data compared with x-ray crystallographic data
    Biochemistry (Mosc)72, 989-993. PubMed  Europe PubMed DOI
62. Szweda,P., Kotlowski,R., lacka,I. and Synowiecki,J.
    Protective effect of lysostaphin from Staphylococcus simulans against growth of Staphylococcus aureus in milk and some other food products
    J Food Saf27, 265-274. DOI
2006
63. Grundling,A. and Schneewind,O.
    Cross-linked peptidoglycan mediates lysostaphin binding to the cell wall envelope of Staphylococcus aureus
    J Bacteriol188, 2463-2472. PubMed  Europe PubMed DOI
64. [YEAR:16-2-2006]Klein,M., Kronke,M. and Krut,O.
    Expression of lysostaphin in HeLa cells protects from host cell killing by intracellular Staphylococcus aureus
    Med Microbiol Immunol195, 159-163. PubMed  Europe PubMed DOI
65. [YEAR:19-9-2006]Sharma,R., Sharma,P.R., Choudhary,M.L., Pande,A. and Khatri,G.S.
    Cytoplasmic expression of mature glycylglycine endopeptidase lysostaphin with an amino terminal hexa-histidine in a soluble and catalytically active form in Escherichia coli
    Protein Expr Purif45, 206-215. PubMed  Europe PubMed DOI  E
66. [YEAR:7-10-2006]Warfield,R., Bardelang,P., Saunders,H., Chan,W.C., Penfold,C., James,R. and Thomas,N.R.
    Internally quenched peptides for the study of lysostaphin: an antimicrobial protease that kills Staphylococcus aureus
    Org Biomol Chem4, 3626-3638. PubMed  Europe PubMed DOI  A
2005
67. Kusuma,C.M. and Kokai-Kun,J.F.
    Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus
    Antimicrob Agents Chemother49, 3256-3263. PubMed  Europe PubMed DOI
68. [YEAR:27-5-2005]Mierau,I., Leij,P., van Swam,I., Blommestein,B., Floris,E., Mond,J. and Smid,E.J.
    Industrial-scale production and purification of a heterologous protein in Lactococcus lactis using the nisin-controlled gene expression system NICE: the case of lysostaphin
    Microb Cell Fact4, 15-15. PubMed  Europe PubMed DOI  E
2004
69. Fan,W., Plaut,K., Bramley,A.J., Barlow,J.W., Mischler,S.A. and Kerr,D.E.
    Persistency of adenoviral-mediated lysostaphin expression in goat mammary glands
    J Dairy Sci87, 602-608. PubMed  Europe PubMed DOI
70. Park,P.W. and Mecham,R.P.
    Lysostaphin
    [ISSN:0-12-079610-4]2, 1004-1005.  V
71. Shah,A., Mond,J. and Walsh,S.
    Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization
    Antimicrobial Agents Chemother48, 2704-2707. PubMed  Europe PubMed DOI
72. Walsh,S., Kokai-Kun,J., Shah,A. and Mond,J.
    Extended nasal residence time of lysostaphin and an anti-staphylococcal monoclonal antibody by delivery in semisolid or polymeric carriers
    Pharm Res21, 1770-1775. PubMed  Europe PubMed DOI
2003
73. [YEAR:7-11-2003]Heath Farris,M., Heath,L.S., Heath,H.E., LeBlanc,P.A., Simmonds,R.S. and Sloan,G.L.
    Expression of the genes for lysostaphin and lysostaphin resistance in streptococci
    FEMS Microbiol Lett228, 115-119. PubMed  Europe PubMed DOI
74. Kokai-Kun,J.F., Walsh,S.M., Chanturiya,T. and Mond,J.J.
    Lysostaphin cream eradicates Staphylococcus aureus nasal colonization in a cotton rat model
    Antimicrobial Agents Chemother47, 1589-1597. PubMed  Europe PubMed DOI
75. Mitra,A., Hruska,K.S., Wellnitz,O., Kerr,D.E., Capuco,A.V. and Wall,R.J.
    Expression of lysostaphin in milk of transgenic mice affects the growth of neonates
    Transgenic Res12, 597-605. PubMed  Europe PubMed DOI
76. von Eiff,C., Kokai-Kun,J.F., Becker,K. and Peters,G.
    In vitro activity of recombinant lysostaphin against Staphylococcus aureus isolates from anterior nares and blood
    Antimicrobial Agents Chemother47, 3613-3615. PubMed  Europe PubMed DOI
77. Walsh,S., Shah,A. and Mond,J.
    Improved pharmacokinetics and reduced antibody reactivity of lysostaphin conjugated to polyethylene glycol
    Antimicrobial Agents Chemother47, 554-558. PubMed  Europe PubMed DOI
2002
78. Dajcs,J.J., Thibodeaux,B.A., Girgis,D.O., Shaffer,M.D., Delvisco,S.M. and O'Callaghan,R.J.
    Immunity to lysostaphin and its therapeutic value for ocular MRSA infections in the rabbit
    Invest Ophthalmol Vis Sci43, 3712-3716. PubMed  Europe PubMed
79. Kiri,N., Archer,G. and Climo,M.W.
    Combinations of lysostaphin with beta-lactams are synergistic against oxacillin-resistant Staphylococcus epidermidis
    Antimicrobial Agents Chemother46, 2017-2020. PubMed  Europe PubMed DOI
2001
80. Climo,M.W., Ehlert,K. and Archer,G.L.
    Mechanism and suppression of lysostaphin resistance in oxacillin-resistant Staphylococcus aureus
    Antimicrobial Agents Chemother45, 1431-1437. PubMed  Europe PubMed DOI
81. Dajcs,J.J., Thibodeaux,B.A., Hume,E.B.H., Zheng,X.D., Sloop,G.D. and O'Callaghan,R.J.
    Lysostaphin is effective in treating methicillin-resistant Staphylococcus aureus endophthalmitis in the rabbit
    Curr Eye Res22, 451-457. PubMed  Europe PubMed DOI
82. Kerr,D.E., Plaut,K., Bramley,A.J., Williamson,C.M., Lax,A.J., Moore,K., Wells,K.D. and Wall,R.J.
    Lysostaphin expression in mammary glands confers protection against staphylococcal infection in transgenic mice
    Nat Biotechnol19, 66-70. PubMed  Europe PubMed DOI
83. Szweda,P., Pladzyk,R., Kotlowski,R. and Kur,J.
    Cloning, expression, and purification of the Staphylococcus simulans lysostaphin using the intein-chitin-binding domain (CBD) system
    Protein Expr Purif22, 467-471. PubMed  Europe PubMed DOI  E
2000
84. Dajcs,J.J., Hume,E.B., Moreau,J.M., Caballero,A.R., Cannon,B.M. and O'Callaghan,R.J.
    Lysostaphin treatment of methicillin-resistant Staphylococcus aureus keratitis in the rabbit
    Invest Ophthalmol Vis Sci41, 1432-1437. PubMed  Europe PubMed
1999
85. Patron,R.L., Climo,M.W., Goldstein,B.P. and Archer,G.L.
    Lysostaphin treatment of experimental aortic valve endocarditis caused by a Staphylococcus aureus isolate with reduced susceptibility to vancomycin
    Antimicrobial Agents Chemother43, 1754-1755. PubMed  Europe PubMed
1998
86. Chan,E.C., Chang,C.A., Wu,T.Z. and Lin,Y.L.
    Effects of recombinant lysostaphin on cytotoxicity and interleukin-8 level in normal human epidermal keratinocytes cell line
    Biotechnol Lett20, 1053-1056.
87. Climo,M.W., Patron,R.L., Goldstein,B.P. and Archer,G.L.
    Lysostaphin treatment of experimental methicillin-resistant Staphylococcus aureus aortic valve endocarditis
    Antimicrobial Agents Chemother42, 1355-1360. PubMed  Europe PubMed
1997
88. Sugai,M., Fujiwara,T., Ohta,K., Komatsuzawa,H., Ohara,M. and Suginaka,H.
    epr, which encodes glycylglycine endopeptidase resistance, is homologous to femAB and affects serine content of peptidoglycan cross bridges in Staphylococcus capitis and Staphylococcus aureus
    J Bacteriol179, 4311-4318. PubMed  Europe PubMed
89. Thumm,G. and Gotz,F.
    Studies on prolysostaphin processing and characterization of the lysostaphin immunity factor (Lif) of Staphylococcus simulans biovar staphylolyticus
    Mol Microbiol23, 1251-1265. PubMed  Europe PubMed DOI
90. Xu,N., Huang,Z.H., de Jonge,B.L. and Gage,D.A.
    Structural characterization of peptidoglycan muropeptides by matrix-assisted laser desorption ionization mass spectrometry and postsource decay analysis
    Anal Biochem248, 7-14. PubMed  Europe PubMed DOI  P
1996
91. Baba,T. and Schneewind,O.
    Target cell specificity of a bacteriocin molecule: a C-terminal signal directs lysostaphin to the cell wall of Staphylococcus aureus
    EMBO J15, 4789-4797. PubMed  Europe PubMed
92. Chan,E.C.
    Expression and purification of recombinant lysostaphin in Escherichia coli
    Biotechnol Lett18, 833-838.  E
1995
93. Park,P.W., Senior,R.M., Griffin,G.L., Broekelmann,T.J., Mudd,M.S. and Mecham,R.P.
    Binding and degradation of elastin by the staphylolytic enzyme lysostaphin
    Int J Biochem Cell Biol27, 139-146. PubMed  Europe PubMed DOI
1994
94. Williamson,C.M., Bramley,A.J. and Lax,A.J.
    Expression of the lysostaphin gene of staphylococcus simulans in a eukaryotic system
    Appl Environ Microbiol60, 771-776. PubMed  Europe PubMed
1993
95. Sakurada,J., Murai,M., Zhijun,L., Usui,A., Seki,K., Kobayashi,K., Sumi,Y., Jitsukawa,H. and Masuda,S.
    Efficient adsorption of lysostaphin on bacterial cells of lysostaphin-resistant Staphylococcus aureus mutant
    Microbiol Immunol37, 29-34. PubMed  Europe PubMed
1987
96. Heath,L.S., Heath,H.E. and Sloan,G.L.
    Plasmid-encoded lysostaphin endopeptidase gene of Staphylococcus simulans biovar staphylolyticus
    FEMS Microbiol Lett44, 129-133.
97. Heinrich,P., Rosenstein,R., Bohmer,M., Sonner,P. and Gotz,F.
    The molecular organization of the lysostaphin gene and its sequences repeated in tandem
    Mol Gen Genet209, 563-569. PubMed  Europe PubMed DOI
98. Recsei,P.A., Gruss,A.D. and Novick,R.P.
    Cloning, sequence, and expression of the lysostaphin gene from Staphylococcus simulans
    Proc Natl Acad Sci U S A84, 1127-1131. PubMed  Europe PubMed
1974
99. Grov,A., Iversen,O.J. and Endresen,C.
    Studies on lysostaphin. Serological cross-reactions between three isolated enzymes
    Eur J Biochem48, 193-198. PubMed  Europe PubMed
1973
100. Iversen,O.J. and Grov,A.
     Studies on lysostaphin. Separation and characterization of three enzymes
     Eur J Biochem38, 293-300. PubMed  Europe PubMed
1970
101. Trayer,H.R. and Buckley,C.E., III
     Molecular properties of lysostaphin, a bacteriolytic agent specific for Staphylococcus aureus
     J Biol Chem245, 4842-4846. PubMed  Europe PubMed
1965
102. Schindler,C.A. and Schuhardt,V.T.
     Purification and properties of lysostaphin - a lytic agent for Staphylococcus aureus
     Biochim Biophys Acta97, 242-250. PubMed  Europe PubMed
1964
103. Schindler,C.A. and Schuhardt,V.T.
     Lysostaphin: a new bacteriolytic agent for the Staphylococcus
     Proc Natl Acad Sci U S A51, 414-421. PubMed  Europe PubMed  U